Literature DB >> 33735889

On-Demand Mobile Health Infrastructure for Remote Rhythm Monitoring within a Wait-and-See Strategy for Recent-Onset Atrial Fibrillation: TeleWAS-AF.

Nikki A H A Pluymaekers1, Rachel M J van der Velden1, Astrid N L Hermans1, Monika Gawalko1, Saskia Buskes1, Joyce J H M W Keijenberg1, Bianca Vorstermans1, Harry J G M Crijns1, Jeroen M Hendriks2,3, Dominik Linz1,4,3,5.   

Abstract

Recently, we introduced the TeleCheck-AF approach, an on-demand mobile health (mHealth) infrastructure using app-based heart rate and rhythm monitoring for 7 days, to support long-term atrial fibrillation (AF) management through teleconsultation. Herein, we extend the mHealth approach to patients with recent-onset AF at the emergency department (ED). In the proposed TeleWAS-AF approach, on-demand heart rate and rhythm monitoring are used to support a wait-and-see strategy at the ED. All stable patients who present to the ED with recent-onset symptomatic AF and who are able to use mHealth solutions for heart rate and rhythm monitoring are eligible for this approach. Patients will receive both education on AF and instructions on the use of the mHealth technology before discharge from the ED. A case coordinator will subsequently check whether patients are able to activate the mHealth solution and to perform heart rate and rhythm measurements. Forty hours after AF onset, the first assessment teleconsultation with the physician will take place, determining the need for delayed cardioversion. After maximal 7 days of remote monitoring, a second assessment teleconsultation may occur, in which the rhythm can be reassessed and further treatment strategy can be discussed with the patients. This on-demand mHealth prescription increases patient involvement in the care process and treatment decision-making by encouraging self-management, while avoiding excess data-load requiring work-intensive and expensive data management. Implementation of the TeleWAS-AF approach may facilitate the management of AF in the ED and reduce the burden on the ED system, which enhances the capacity for health care utilization.
© 2021 S. Karger AG, Basel.

Entities:  

Keywords:  Atrial fibrillation; Cardioversion; Mobile health; Recent-onset atrial fibrillation; Wait-and-see strategy

Year:  2021        PMID: 33735889     DOI: 10.1159/000514156

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  3 in total

1.  Defining the benefit: Cardioversion of persistent atrial fibrillation.

Authors:  Sotirios Nedios; David Duncker
Journal:  Int J Cardiol Heart Vasc       Date:  2021-09-30

2.  Self-Reported Mobile Health-Based Risk Factor and CHA2DS2-VASc-Score Assessment in Patients With Atrial Fibrillation: TeleCheck-AF Results.

Authors:  Astrid N L Hermans; Monika Gawałko; Henrike A K Hillmann; Afzal Sohaib; Rachel M J van der Velden; Konstanze Betz; Dominique Verhaert; Daniel Scherr; Julia Meier; Arian Sultan; Daniel Steven; Elena Terentieva; Ron Pisters; Martin Hemels; Leonard Voorhout; Piotr Lodziński; Bartosz Krzowski; Dhiraj Gupta; Nikola Kozhuharov; Henri Gruwez; Kevin Vernooy; Nikki A H A Pluymaekers; Jeroen M Hendriks; Martin Manninger; David Duncker; Dominik Linz
Journal:  Front Cardiovasc Med       Date:  2022-01-19

3.  Remote patient monitoring for chronic heart failure in France: When an innovative funding program (ETAPES) meets an innovative solution (Satelia® Cardio).

Authors:  N Pages; F Picard; F Barritault; W Amara; S Lafitte; P Maribas; P Abassade; J Ph Labarre; R Boulestreau; H Chaouky; M Abdennadher; H Lemieux; R Lasserre; C Bedel; L Betito; S Nisse-Durgeat; B Diebold
Journal:  Digit Health       Date:  2022-08-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.